PUBLISHER: The Business Research Company | PRODUCT CODE: 1945292
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945292
Hereditary genetic testing analyzes DNA to detect inherited gene mutations that may increase the risk of disease. It helps identify genetic conditions that may be passed from parents to children, including cancers, heart diseases, and rare inherited disorders.
The primary types of hereditary genetic testing include predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others. Predictive and presymptomatic testing helps identify individuals with a genetic likelihood of developing specific diseases before clinical symptoms appear. The technologies used include cytogenetic testing, biochemical testing, and molecular testing. Clinical applications include cancer genetic testing, cardiovascular genetic testing, neurological genetic testing, and rare disease genetic testing. The end users consist of hospitals and clinics, diagnostic laboratories, research institutes, and direct-to-consumer (DTC) genetic testing providers.
Tariffs are impacting the hereditary genetic testing market by increasing costs for imported laboratory instruments, reagents, and sequencing equipment, impacting overall testing affordability. Molecular testing and pharmacogenomic testing segments are most affected, particularly in regions such as Asia-Pacific and Latin America that rely heavily on imported diagnostic technologies. These cost pressures have slowed adoption in price-sensitive markets. However, tariffs have also encouraged domestic manufacturing of testing kits and reagents, fostering local innovation and strengthening regional diagnostic capabilities.
The hereditary genetic testing market research report is one of a series of new reports from The Business Research Company that provides hereditary genetic testing market statistics, including hereditary genetic testing industry global market size, regional shares, competitors with a hereditary genetic testing market share, detailed hereditary genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary genetic testing industry. This hereditary genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hereditary genetic testing market size has grown rapidly in recent years. It will grow from $23.88 billion in 2025 to $26.56 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of hereditary disorders, growing clinical adoption of molecular diagnostics, expansion of diagnostic laboratories, rising awareness of genetic diseases, availability of basic genetic testing technologies.
The hereditary genetic testing market size is expected to see rapid growth in the next few years. It will grow to $40.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to advancements in next-generation sequencing technologies, growing demand for personalized medicine, expansion of pharmacogenomic applications, increasing healthcare spending on preventive care, wider integration of genetic counseling services. Major trends in the forecast period include rising adoption of preventive and predictive genetic testing, increasing demand for early cancer risk assessment, growth of direct-to-consumer genetic testing services, expansion of prenatal and newborn genetic screening, rising awareness of inherited cardiovascular and rare diseases.
The increasing prevalence of cancer is increasingly supporting the expansion of the hereditary genetic testing market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth with the potential to invade or spread to other parts of the body. The growing prevalence of cancer is influenced by aging populations, lifestyle changes, environmental exposures, genetic predispositions, and improved diagnostic capabilities. Hereditary genetic testing helps identify inherited genetic mutations linked to increased cancer risk, enabling early surveillance and preventive strategies. For example, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with projections indicating growth to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the increasing cancer burden is contributing to the expansion of the hereditary genetic testing market.
Leading companies operating in the hereditary genetic testing market are focusing on developing advanced genomic solutions, such as multi-cancer multigene panels, to support early detection and personalized treatment strategies. Multi-cancer multigene panels analyze multiple genes simultaneously to identify mutations linked to different cancers, aiding risk assessment and tailored care. For example, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, launched the Riskguard hereditary cancer test. This test delivers personalized insights into gene-specific and familial cancer risks using a blood or saliva sample, supporting informed screening decisions, treatment planning, and family risk evaluation.
In August 2024, Laboratory Corporation of America Holdings (Labcorp), a US-based laboratory services company, acquired selected assets of Invitae Corporation for an undisclosed amount. With this acquisition, Labcorp aims to expand its specialty testing capabilities and strengthen its use of genetic data to improve clinical trials and treatment approaches in oncology and select rare diseases. Invitae Corporation is a US-based provider of medical genetics services, including genetic testing solutions for oncology and rare diseases.
Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC, Centogene N.V., CooperSurgical Inc., Sema4
North America was the largest region in the hereditary genetic testing market in 2025 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hereditary genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hereditary genetic testing market includes revenues earned by entities by providing services such as carrier screening, prenatal testing, and newborn screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hereditary Genetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hereditary genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hereditary genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary genetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.